Intervention Protocol

Minimally invasive surgery versus radiotherapy/chemoradiotherapy for early-stage oropharyngeal carcinoma

  1. James Howard1,*,
  2. Liam Masterson1,
  3. Raghav C Dwivedi1,
  4. Faruque Riffat2,
  5. Richard Benson3,
  6. Sarah Jefferies4,
  7. Piyush Jani1,
  8. James R Tysome4,
  9. Chris Nutting5

Editorial Group: Cochrane Ear, Nose and Throat Disorders Group

Published Online: 20 FEB 2014

DOI: 10.1002/14651858.CD010963


How to Cite

Howard J, Masterson L, Dwivedi RC, Riffat F, Benson R, Jefferies S, Jani P, Tysome JR, Nutting C. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for early-stage oropharyngeal carcinoma (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No.: CD010963. DOI: 10.1002/14651858.CD010963.

Author Information

  1. 1

    Cambridge University Hospitals NHS Foundation Trust, ENT Department, Cambridge, UK

  2. 2

    University of Sydney, Westmead Hospital, Sydney, Australia

  3. 3

    Addenbrooke's Hospital, Oncology Centre, Cambridge, UK

  4. 4

    Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

  5. 5

    Royal Marsden Hospital, Head and Neck Unit, London, UK

*James Howard, ENT Department, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. j.howard@doctors.org.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 20 FEB 2014

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy of transoral robotic surgery or transoral laser microsurgery for early-stage (T1-2, N0-2) oropharyngeal carcinoma in comparison to radiotherapy/chemoradiotherapy.